NCT06419140View on ClinicalTrials.gov

Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

December 31, 2025

Conditions
Gastric Cancer
Interventions
DRUG

Standard SOX/XELOX adjuvant chemotherapy plus multimodal rehabilitation

Motivational counseling to perform nutritional, psychological, and exercise inventions

Trial Locations (1)

310022

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors
lead

Zhejiang Cancer Hospital

OTHER

NCT06419140 - Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy | Biotech Hunter | Biotech Hunter